Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRSA Prophylaxis for Lower Limb Amputation
2004-001701-97Phase 4Completed
- Sponsor
- Royal Berkshire NHS Foundation Trust
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of teicoplanin in Staphylococcus aureus infection, surgical site infection (SSI) and arteriosclerosis obliterans (2 arms), sponsored by Royal Berkshire NHS Foundation Trust. Primary endpoints: Primary wound healing and Postoperative wound MRSA infection. Started Nov 2005; status: completed.
02
Drugs
teicoplanin
03
Conditions
Staphylococcus aureus infectionsurgical site infection (SSI)arteriosclerosis obliterans
Beyond the preview
Go deeper on 2004-001701-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001701-97.